Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

 in 2023, where she produces written content covering multiple disease states.

She has a BA in journalism from Seton Hall University. You can connect with Brooke on 

Articles

A positive association was found between osteoarthritis and overactive bladder (OAB), but rheumatoid arthritis and psoriatic arthritis were not significantly correlated with the condition.

Findings Suggest Potential Link Between Overactive Bladder, Osteoarthritis

Cameron Santoro is an associate editor for 

), AJMC.com, and The Center for Biosimilars

New 2-year data show the long-term effects of bimekizumab on hidradenitis suppurativa, indicating its potential as a valuable treatment option for patients.

Bimekizumab for Hidradenitis Suppurativa Offers Durable Disease Control in Long-Term Data

Rose is an associate editorial director at 

She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on 

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial. 

Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

The large UK Biobank study finds depression a significant risk predictor for developing chronic conditions such as osteoarthritis, hypertension, and gastro-oesophageal reflux disease.

Adults With Depression Likely Develop Physical Conditions 30% Faster

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Gastroenterology

Hematology

Hepatology

Immunology

Infectious Disease

MASH

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

Multidisciplinary Approaches to Paraneoplastic LEMS: Insights for Healthcare Decision-Makers 

Strategies to Alleviate the Clinical and Economic Burden of LEMS

Video content above is prompted by the following:

What strategies have been successful in mitigating the economic impact of Lambert-Eaton myasthenic syndrome (LEMS) on patients and health care systems?

How can a multidisciplinary approach reduce the clinical and economic burden of LEMS on health care delivery?

Videos

A medical expert discusses the key aspects of Lambert-Eaton Myasthenic Syndrome (LEMS) in the context of small cell lung cancer (SCLC), including its differential diagnosis, long-term effects, economic burden, and how a multidisciplinary approach can optimize patient care and reduce health care 

A medical expert discusses how Lambert-Eaton myasthenic syndrome is closely linked to small cell lung cancer, the challenges in differentiating it from other neuromuscular disorders like myasthenia gravis, and the impact of dual diagnosis on cancer care and patient outcomes.

LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

A medical expert discusses strategies that have successfully mitigated the economic impact of LEMS on patients and health care systems, and how a multidisciplinary approach can reduce the clinical and economic burden of LEMS on health care delivery.

A medical expert discusses how disparities in health care access affect the management and outcomes of Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer, how health care providers can quantify the economic burden of LEMS on both patients and health care systems, the role of patient-reported outcomes in providing deeper insights into the clinical and economic burden of LEMS, and how health systems can utilize real-world data to better understand the indirect costs of LEMS.

The Clinical and Economic Impact of LEMS in SCLC Care

A panelist discusses how enhanced screening protocols combined with predictive analytics can accelerate Lambert-Eaton myasthenic syndrome (LEMS) detection in high-risk populations like patients with small cell lung cancer (SCLC) while also exploring the potential of telemedicine to improve early diagnosis in underserved communities.

Using Technology for Early Detection of LEMS

A panelist discusses how comprehensive care coordination between specialists, proactive adverse effect management, and innovative care models can optimize treatment outcomes for Lambert-Eaton myasthenic syndrome (LEMS) patients, particularly those with dual diagnoses like small cell lung cancer (SCLC), while ensuring both clinical effectiveness and cost-efficiency through managed care strategies.

Team- and System-Based Approaches to Managing LEMS and Ensuring Access 

A panelist discusses how digital patient engagement tools and collaboration with advocacy groups can enhance treatment adherence and care coordination while providing vital support and resources for individuals managing Lambert-Eaton myasthenic syndrome (LEMS).

The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

A panelist discusses how strategic managed care partnerships can streamline care transitions between treatment settings to ensure uninterrupted support and monitoring for patients with Lambert-Eaton myasthenic syndrome.

Managed Care Partnerships and Continuity of Care

Mitigating the economic impact of Lambert-Eaton myasthenic syndrome (LEMS) involves implementing strategies that focus on early diagnosis, personalized treatment plans, and patient education. Successful approaches include optimizing pharmacotherapy to reduce hospitalizations and leveraging telemedicine for ongoing patient management. A multidisciplinary approach, involving neurologists, physiotherapists, and occupational therapists, can enhance patient outcomes and reduce healthcare costs by streamlining care coordination and improving quality of life. This collaborative model not only addresses the clinical aspects of LEMS but also alleviates the financial strain on healthcare systems and patients.

Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care

EP: 4.Using Technology for Early Detection of LEMS

EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access

EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

EP: 7.Managed Care Partnerships and Continuity of Care